To test blood samples from volunteer donors of whole blood and blood components using a new investigational test that detects human immunodeficiency virus (HIV) infection. Results will be compared to the current HIV screening assay.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Enrollment
24,111
Test blood samples with investigational HIV assay. If results are reactive, donors may be deferred and asked to return for a follow-up blood draw.
Mississippi Valley Regional Blood Center
Davenport, Iowa, United States
Community Blood Center of Greater Kansas City
Kansas City, Missouri, United States
Community Blood Center
Dayton, Ohio, United States
American Red Cross
Philadelphia, Pennsylvania, United States
PRISM HIV O Plus Test Data for Specificity
Negative HIV status was determined by the results of the HIV-1/HIV-2 comparator assay and HIV-1 qualitatitve RNA.
Time frame: 12 months
PRISM HIV O Plus Test Data for Sensitivity
Final HIV status was determined according to a supplemental testing algorithm for specimens positive by the investigational assay. Supplemental testing involved HIV-1 Western blot, HIV-2 EIA, HIV-2 Western blot and HIV-1 ribonucleic acid (RNA).
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Interstate Blood Bank, Inc.
Memphis, Tennessee, United States
South Texas Blood And Tissue Center
San Antonio, Texas, United States
Puget Sound Blood Center
Renton, Washington, United States